Search details
1.
The value of baseline 18F-sodium fluoride and 18F-choline PET activity for identifying responders to radium-223 treatment in castration-resistant prostate cancer bone metastases.
Eur Radiol
; 34(2): 1146-1154, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37615760
2.
Discovery of pre-therapy 2-deoxy-2-18F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients.
Eur J Nucl Med Mol Imaging
; 46(2): 455-466, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30173391
3.
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
BMC Med Imaging
; 19(1): 90, 2019 11 15.
Article
in English
| MEDLINE | ID: mdl-31730466
4.
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 44(11): 1832-1844, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28612079
5.
Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.
Radiology
; 276(3): 883-93, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25897473
6.
Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R-GEM-P) is an effective regimen in relapsed diffuse large B-cell lymphoma.
Eur J Haematol
; 94(3): 219-26, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25039915
7.
Childhood extracranial neoplasms: the role of imaging in drug development and clinical trials.
Pediatr Radiol
; 45(11): 1600-15, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26045035
8.
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphoma.
Ann Hematol
; 93(5): 827-34, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24158386
9.
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response.
JNCI Cancer Spectr
; 7(6)2023 Oct 31.
Article
in English
| MEDLINE | ID: mdl-37788117
10.
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
Cancer Imaging
; 23(1): 57, 2023 Jun 08.
Article
in English
| MEDLINE | ID: mdl-37291656
11.
The Diagnostic Accuracy of 18 F-FGD-PET/CT for Cancer of the Gallbladder: A Retrospective Study.
World J Nucl Med
; 21(2): 112-119, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35865160
12.
Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.
Curr Oncol
; 29(4): 2174-2184, 2022 03 22.
Article
in English
| MEDLINE | ID: mdl-35448150
13.
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Clin Cancer Res
; 28(21): 4634-4641, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-35984704
14.
The diagnostic utility of the flare phenomenon on bone scintigraphy in staging prostate cancer.
Eur J Nucl Med Mol Imaging
; 38(1): 7-13, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20697891
15.
Whole-body diffusion-weighted MRI in lymphoma-comparison of global apparent diffusion coefficient histogram parameters for differentiation of diseased nodes of lymphoma patients from normal lymph nodes of healthy individuals.
Quant Imaging Med Surg
; 11(8): 3549-3561, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34341730
16.
Effect of 18F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.
Int J Radiat Oncol Biol Phys
; 107(2): 316-324, 2020 06 01.
Article
in English
| MEDLINE | ID: mdl-32068113
17.
Prospective, Multisite, International Comparison of 18F-Fluoromethylcholine PET/CT, Multiparametric MRI, and 68Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes.
J Nucl Med
; 60(6): 794-800, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30442757
18.
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.
Nucl Med Commun
; 40(7): 662-674, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31145206
19.
The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of 18F-Fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.
J Nucl Med
; 60(9): 1253-1258, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30902875
20.
Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer: A Randomized, Open-label Phase 2 Study.
JAMA Oncol
; 5(8): 1159-1167, 2019 Aug 01.
Article
in English
| MEDLINE | ID: mdl-31246234